Clinical Trials Logo

Insulin Sensitivity clinical trials

View clinical trials related to Insulin Sensitivity.

Filter by:

NCT ID: NCT02978001 Completed - Insulin Sensitivity Clinical Trials

Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With Psoriasis

Start date: August 2016
Phase:
Study type: Observational

The pathophysiological mechanisms explaining the association between psoriasis and type 2 diabetes are largely unknown but it has been hypothesized that systemic inflammation found in both psoriasis and type 2 diabetes might play a role. In a recent study hyperinsulinaemic euglycaemic clamps were performed and it showed that normal glucose-tolerant patients with moderate to severe psoriasis had lower whole-body insulin sensitivity during insulin stimulation compared to healthy matched controls. Thus, the increased risk of type 2 diabetes in patients with psoriasis appears to include defects in the glucose metabolism linked to psoriasis itself. However, the methods applied did not allow a detailed characterization of the metabolism in patients with psoriasis. Tracer technique combined with indirect calorimetry has never been applied to study hepatic and whole body insulin sensitivity, and glucose and fat oxidation, during basal conditions or during insulin stimulation in patients with psoriasis. Aim of study: The aim of this study is to investigate hepatic and whole body insulin sensitivity and glucose and fat oxidation during both basal and insulin-stimulated conditions in patients with psoriasis.

NCT ID: NCT02961179 Completed - Type2 Diabetes Clinical Trials

Dairy Products, Diabetes and Genetics

PRODIGE
Start date: January 2017
Phase: N/A
Study type: Interventional

This study will investigate the in-depth the benefits of dairy consumption on glucose metabolism in patients at risk of type 2 diabetes using novel genomics methodology.To do so, 33 individuals at risk of type 2 diabetes will be randomly subjected to an intervention study including a 6-week intensive dairy product consumption period and a 6-week dietary counselling period.

NCT ID: NCT02913079 Completed - Physical Activity Clinical Trials

The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels

Start date: September 2016
Phase: N/A
Study type: Interventional

Context and Rationale: Uninterrupted sitting is associated with increased risk of diabetes, heart disease, and death, even among people who are physically active. These relationships are likely due to increases in post-meal blood sugar observed when people sit for long periods (e.g. > 1 hour) without interruption. In contrast to sitting, standing results in large reductions in post-meal blood sugar levels. Our group has recently shown that sit-stand desks result in large (e.g. 2.5 hour/day) reductions in occupational sitting time. Taken together, these findings suggest that sit-stand desks may help to reduce post-meal blood sugar levels. However, this has yet to be examined in the field. Theoretical Approach and Objectives: The objective of this randomized crossover study is to determine whether people have lower blood sugar when using a sit-stand desk, in comparison to a desk that can only be used while sitting. Methods and Procedures: Sixteen participants will be asked to wear a continuous glucose monitor to measure their blood sugar levels during 2 separate conditions. During one condition, they will be asked to use a sit-stand desk to sit and/or stand as much as they like during 1 workday. During the other condition, they will be asked to work at a seated desk for 1 workday. Participants will be provided with identical meals to eat during each of the two conditions. We hypothesize that participants will have lower blood sugar levels on the day when they use the sit-stand desk, in comparison to the day using a traditional seated desk. Significance and Future Use: If our results support this hypothesis, this would suggest that sit-stand desks may be a useful way to reduce blood sugar levels in people at risk for diabetes. This could also lead to larger population-based interventions studying the health impact of sit-stand desks.

NCT ID: NCT02890108 Recruiting - Insulin Sensitivity Clinical Trials

Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility

Start date: August 2016
Phase: N/A
Study type: Interventional

This study will compare the effect of acute consumption of two carbonated drinks, sweetened with sugar or with non-caloric sweeteners, over the insulin response of healthy adults who normally consumed foods or drinks that contain non-caloric sweeteners

NCT ID: NCT02870088 Completed - Insulin Sensitivity Clinical Trials

The Effect of Breaking Prolonged Sitting on Adipose Tissue and Metabolism

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this project is to investigate the effect of breaking prolonged sitting on acute adipose tissue and metabolic responses.

NCT ID: NCT02852044 Completed - Hyperglycemia Clinical Trials

The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion

Start date: November 2015
Phase: N/A
Study type: Interventional

For decades, it has been known that post-meal blood glucose concentrations were associated with the risk of T2D, which was reflected in early diagnostic guidelines. The oral glucose tolerance test (OGTT) has been used since at least 1923 and has remained the most common test for assessing glucose tolerance. Arterial blood (or arterialised blood using heated hand technique) is most appropriate for determining glucose tolerance and insulin sensitivity since this best represents the concentrations of metabolites and hormones that peripheral tissues are exposed to. It is essential to investigate whether venous blood (sometimes used during an OGTT) is representative of arterialised blood during an OGTT, and under different metabolic conditions. The investigators want to understand whether OGTT-derived insulin sensitivity indices differ from venous and arterialised blood; and 2) investigate whether metabolic status (i.e. rest vs lower-limb exercise) influences the difference between forearm venous and arterialised concentrations of glucose and insulin during an OGTT.

NCT ID: NCT02740439 Recruiting - Insulin Resistance Clinical Trials

Persea Americana for Total Health (PATH ) Study

PATH
Start date: February 2016
Phase: N/A
Study type: Interventional

The proposed work will investigate the effects of avocados on abdominal obesity and glycemic control among overweight/obese adults.

NCT ID: NCT02700698 Completed - Healthy Clinical Trials

Mitochondrial Function in Circulating Cells and Muscle Tissue

MitoWomen
Start date: September 2016
Phase:
Study type: Observational

The main goal of this project is to determine whether mitochondrial function in circulating cells is related to that measured in the muscle fibers of the same subjects.

NCT ID: NCT02686996 Recruiting - Insulin Sensitivity Clinical Trials

The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk

Start date: February 13, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether carnosine supplementation in overweight/obese individuals can improve insulin secretion and/or insulin resistance by decreasing sub clinical inflammation. The investigators hypothesise that carnosine supplementation will reduce type 2 diabetes and cardiovascular risk factors by lowering chronic low-grade inflammation (CLI), oxidative stress, advanced glycation end products (AGEs), and advanced lipoxidation end products (ALEs). Aim :To determine the capacity of carnosine supplementation to decrease major risk factors for type 2 diabetes and cardiovascular disease and identify metabolic pathways involved, specifically by: 1. Reducing diabetes risk (insulin sensitivity; secretory function and glucose tolerance) 2. Improving cardiovascular risk factors (lipids; arterial (aortic) stiffness; central blood pressure (cBP); endothelial function). 3. Decreasing the CLI, oxidative stress, AGEs, and ALEs, and increase detoxification of reactive carbonyl species (RCSs).

NCT ID: NCT02659748 Active, not recruiting - Type 2 Diabetes Clinical Trials

Milk Fat Intake and Metabolic Health Markers

DMFMHM
Start date: January 2014
Phase: N/A
Study type: Interventional

This study investigates the effects of bioactive fatty acids in full fat dairy (whole yogurt), on insulin action, calorie needs, blood lipids, immune function, and body composition in normal and overweight male and female volunteers.